medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2021-27-56-60medalphabet-2272Research ArticleВ ПОМОЩЬ ПРАКТИЧЕСКОМУ ВРАЧУТактика ведения пациентов с себорейным дерматитомManagement of patients with seborrheic dermatitishttps://orcid.org/0000-0001-5937-606XМаркеловаЕ. М.MarkelovaE. M.

Маркелова Екатерина Максимовна, врач-дерматовенеролог, косметолог

Москва

Markelova Ekaterina M., dermatovenerologist, cosmetologist

Moscow

genslerkatya@rambler.ruФГБУ «Поликлиника № 5» Управления делами Президента Российской ФедерацииРоссияPoliclinic No. 5 of the Administrative Department of the President of RussiaRussian Federation202101112021027Дерматология (2)5660Copyright © Маркелова Е.М., 20212021Маркелова Е.М.Markelova E.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/2272

Статья носит обзорный характер и содержит актуальную информацию о существующих в настоящее время современных методах лечения различных форм себорейного дерматита (СД). Приводятся данные о современных способах ведения пациентов с тяжелым течением СД, позволяющих на длительное время добиться регресса кожных высыпаний и значительно улучшить качество жизни пациента.

The article is of the overview nature and contains up-to-date information about the current methods of treatment of various forms of seborrheic dermatitis (SD). The data on modern methods of management of patients with severe forms of SD, allowing for a long time to achieve regression of skin rashes and significantly improve the quality of life of the patient, are presented.

себорейный дерматитMalassezia spp.наружная и системная терапия себорейного дерматитакортикостероидыкетоконазолизотретиноинseborrheic dermatitisMalassezia spp.external and systemic therapy of seborrheic dermatitiscorticosteroidsketoconazoleisotretinoinReferencesBorda LJ, Wikramanayake TC. Seborrheic Dermatitis and Dandruff: A Comprehensive Review. J Clin Investig Dermatol. 2015; 3 (2): 10.Borda LJ, Wikramanayake TC. Seborrheic Dermatitis and Dandruff: A Comprehensive Review. J Clin Investig Dermatol. 2015; 3 (2): 10.Т. Г. Храмова. Себорейный дерматит волосистой части головы: от диагностики к лечению: учебное пособие. ГБОУ ВПО «ИГМУ» Минздрава России, кафедра дерматовенерологии ФПК и ППС. Иркутск, 2016. 46 с.Khramova. Seborrheic dermatitis of the scalp: from diagnosis to treatment: a textbook. ISMU of the Ministry of Health of Russia, Department of Dermatovenereology of the FPC and PPS. Irkutsk, 2016. 46 pages (in Russian).Sébastien Menzinger, Emmanuel Laffitte.Dermiteséborrhéique: manifestations cliniques et priseen charge. RevMedSuisse 2011; volume 7. 752–758.Sébastien Menzinger, Emmanuel Laffitte.Dermiteséborrhéique: manifestations cliniques et priseen charge. RevMedSuisse 2011; volume 7. 752–758.Jonas A. Adalsteinsson, Shivani Kaushik, Sonal Muzumdar, Emma Guttman-Yassky, Jonathan Ungar. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Experimental Dermatology Volume 29, Issue 5 p. 481–489 03 March 2020.Jonas A. Adalsteinsson, Shivani Kaushik, Sonal Muzumdar, Emma Guttman-Yassky, Jonathan Ungar. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Experimental Dermatology Volume 29, Issue 5 p. 481–489 03 March 2020.Ro B.I., Dawson T.L. The role of sebaceous gland activity and scalp microflopal metabolism in the etiology of seborrheic dermatitis and dandruff. Investig. Dermatol. Symp. Proc. 2005. Vol. 10. P. 194–7.Ro B.I., Dawson T.L. The role of sebaceous gland activity and scalp microflopal metabolism in the etiology of seborrheic dermatitis and dandruff. Investig. Dermatol. Symp. Proc. 2005. Vol. 10. P. 194–7.Полонская А.С., Шатохина Е.А., Круглова Л.С. Себорейный дерматит: современные представления об этиологии, патогенезе и подходах к лечению. Клиническая дерматология и венерология. 2020; 19 (4): 451–458. https://doi. org/10.17116/klinderma202019041451Polonskaya A.S., Shatokhina E.A., Kruglova L.S. Seborrheic dermatitis: modern ideas about the etiology, pathogenesis and treatment approaches. Clinical Dermatology and Venereology. 2020; 19 (4): 451–458. https://doi.org/10.17116/ klinderma202019041451 (in Russian).Вольф К., Голдсмит Л.А., Кац С.И., Джилкрест Б.А., Паллер Э.С., Леффель Д. Дж. Дерматология Фицпатрика в клинической практике. В 3 т. Том 1, гл. 22. М.: Издательство Бином. Лаборатория знаний. 2012. С. 235–242.Wolf K., Goldsmith L.A., Katz S.I., Gilchrist B.A., Baller E. S., Leffel D. J. Fitzpatrick dermatology in clinical practice. In 3 vols. Volume 1, ch. 22. M.: Binom Publishing House. Knowledge Lab. 2012. pp. 235–242 (in Russian).Dan Tucker, Sadia Masood. Seborrheic Dermatitis In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020 Jan. 2020 Oct 3.Dan Tucker, Sadia Masood. Seborrheic Dermatitis In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020 Jan. 2020 Oct 3.Пильгуй Э. И., Мурашкин Н.Н. Клинические рекомендации по ведению детей с себорейным дерматитом. Педиатрическая фармакология. 2015; 12 (5): 559–561. DOI: 10.15690/pf.v12i5.1458.Pilgui E.I., Murashkin N.N. Clinical recommendations for the management of children with seborrheic dermatitis. Pediatricheskaia farmakologiia. 2015; 12 (5): 559–561. DOI: 10.15690/pf.v12i5.1458 (in Russian).Монахов С.А. Новое в терапии себорейного дерматита. Клин. дерматол. и венерол. 2010. № 1. С. 79–82.Monakhov S.A. New in the treatment of seborrheic dermatitis. Clinical Dermatology and Venereology. 2010. No. 1. P. 79–82 (in Russian).Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review. J Dermatolog Treat. 2019; 30 (2): 158–169. https://doi.org/10.1080 /09546634.2018.1473554Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review. J Dermatolog Treat. 2019; 30 (2): 158–169. https://doi.org/10.1080 /09546634.2018.1473554Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN (2015) Topical antifungals for seborrheic dermatitis. Cochrane Database Syst Rev (4): 1–229.Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN (2015) Topical antifungals for seborrheic dermatitis. Cochrane Database Syst Rev (4): 1–229.Л.С. Круглова, Д.В. Федоров, А. Г. Стенько, Н.В. Грязева, А.Б. Яковлев. Актуальные рекомендации по применению многокомпонентного препарата в дерматологии. Медицинский алфавит. 2019. Т. 2. № 26 (401). С. 67–72. https://doi.org/10.33667/2078–5631–2019–2–26(401)-67–72 L. S.L. S. Kruglova, D. V. Fedorov, A. G. Stenko, N. V. Gryazeva, A. B. Yakovlev. Current recommendations for the use of a multicomponent drug in dermatology. Medical alphabet. 2019. Vol. 2. No. 26 (401). pp. 67–72. https://doi. org/10.33667/2078–5631–2019–2–26(401)-67–72 (in Russian).Schmidt-Rose T, Braren S, Folster H, Hillemann T, Oltrogge B, et al. (2011) Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff. Int J Cosmet Sci 33 (3): 276–282.Schmidt-Rose T, Braren S, Folster H, Hillemann T, Oltrogge B, et al. (2011) Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff. Int J Cosmet Sci 33 (3): 276–282.Панюкова С. В., Пирузян А. Л., Корсунская И. М. Себорейный дерматит: как помочь пациенту. Consilium Medicum. 2020; 22 (7): 46–48. DOI: 10.26442/20751753.2020.7.200314Panyukova S. V., Piruzyan A. L., Korsunskaya I. M. Seborrheic dermatitis: how to help a patient. Consilium Medicum. 2020; 22 (7): 46–48. DOI: 10.26442/20751753.2020.7.200314 (in Russian).Schmidt-Rose T, et al. Efficacy of a Piroctone Olamine/climbazol Shampoo in Comparison with a Zinc Pyrithione Shampoo in Subjects with Moderate to Severe Dandruff. International Journal of Cosmetic Science. Vol. 33, No. 3, 2011, pp. 276–82.Schmidt-Rose T, et al. Efficacy of a Piroctone Olamine/climbazol Shampoo in Comparison with a Zinc Pyrithione Shampoo in Subjects with Moderate to Severe Dandruff. International Journal of Cosmetic Science. Vol. 33, No. 3, 2011, pp. 276–82.Гаджигороева А.Г. Новые возможности в лечении себорейного дерматита волосистой части головы. Клиническая дерматология и венерология. 2005. № 2 C. 70–72.Gadzhigoroeva A. G. New opportunities in the treatment of seborrheic dermatitis of the scalp. Clinical Dermatology and Venereology. 2005. No. 2. P. 70–72 (in Russian).Goldust M, Rezaee E, Raghifar R, Hemayat S (2013) Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs tacrolimus 0.03% cream. Ann Parasitol 59 (2): 73–77.Goldust M, Rezaee E, Raghifar R, Hemayat S (2013) Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs tacrolimus 0.03% cream. Ann Parasitol 59 (2): 73–77.Sugita T, Tajima M, Tsubuku H, Tsuboi R, Nishikawa A. A new calcineurin inhibitor, pimecrolimus, inhibits the growth of Malassezia spp. Antimicrob Agents Chemother. 2006; 50 (8): 2897–2898. https://doi.org/10.1128/ AAC.00687–06Sugita T, Tajima M, Tsubuku H, Tsuboi R, Nishikawa A. A new calcineurin inhibitor, pimecrolimus, inhibits the growth of Malassezia spp. Antimicrob Agents Chemother. 2006; 50 (8): 2897–2898. https://doi.org/10.1128/ AAC.00687–06Болотная Л. А. Возможности такролимуса в лечении больных хроническими дерматозами. Украинский журнал дерматологии, венерологии, косметологии. 2012; 2 (42): 27–32.Bolotnaya L. A. Capabilities of tacrolimus in the treatment of patients with chronic dermatoses. Ukrainian Journal of Dermatology, Venereology, Cosmetology. 2012; 2 (42): 27–32. (in Russian)Ang-Tiu CU, Meghrajani CF Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials. Expert Rev Clin Pharmacol. 2012. Vol. 5. No.1. P. 91–97.Ang-Tiu CU, Meghrajani CF Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials. Expert Rev Clin Pharmacol. 2012. Vol. 5. No.1. P. 91–97.Gupta AK, Richardson M, Paquet M. Systematic review of oral treatments for seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2014; 28 (1): 16–26. https://doi.org/10.1111/jdv.12197Gupta AK, Richardson M, Paquet M. Systematic review of oral treatments for seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2014; 28 (1): 16–26. https://doi.org/10.1111/jdv.12197Ghodsi SZ, Abbas Z, Abedeni R. Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial. Am J Clin Dermatol. 2015; 16 (5): 431–437. https://doi.org/10.1007/s40257–015–0133–9Ghodsi SZ, Abbas Z, Abedeni R. Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial. Am J Clin Dermatol. 2015; 16 (5): 431–437. https://doi.org/10.1007/s40257–015–0133–9Cömert A, Bekiroglu N, Gürbüz O, Ergun T. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study. Am J Clin Dermatol. 2007; 8 (4): 235–238. https://doi.org/10.2165/00128071– 200708040–00005Cömert A, Bekiroglu N, Gürbüz O, Ergun T. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study. Am J Clin Dermatol. 2007; 8 (4): 235–238. https://doi.org/10.2165/00128071– 200708040–00005Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology. 1998; 196 (1): 140–147. https://doi.org/10.1159/000017848Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology. 1998; 196 (1): 140–147. https://doi.org/10.1159/000017848King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cisretinoic acid on acne, sebum excretion rate and microbial population. BrJ Dermatol.1982; 107 (5): 583–90.King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cisretinoic acid on acne, sebum excretion rate and microbial population. BrJ Dermatol.1982; 107 (5): 583–90.De Souza Leão Kamamoto C, Sanudo A, Hassun KM, Bagatin E. Low-dose oral isotretinoin for moderate to severe seborrhea and seborrheic dermatitis: a randomized comparative trial. Int J Dermatol. 2017; 56 (1): 80–85. https://doi. org/10.1111/ijd.13408De Souza Leão Kamamoto C, Sanudo A, Hassun KM, Bagatin E. Low-dose oral isotretinoin for moderate to severe seborrhea and seborrheic dermatitis: a randomized comparative trial. Int J Dermatol. 2017; 56 (1): 80–85. https://doi. org/10.1111/ijd.13408Круглова Л. С., Котенко К. В., Коржачкина Н. Б., Тубровская С.Н. Физиотерапия в дерматологии. ГЭОТАР-Медиа. 304 стр.Kruglova L.S., Kotenko K.V., Korzhachkina N.B., Tubrovskaya S.N. Physiotherapy in dermatology. GEOTAR-Media. 304 pages.Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A. Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol. 2005; 52 (4): 660–670. https://doi.org/10.1016/j.jaad.2004.08.047Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A. Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol. 2005; 52 (4): 660–670. https://doi.org/10.1016/j.jaad.2004.08.047Dahl KB, Reymann F. Photochemotherapy in erythrodermic seborrhoic dermatitis. Arch Dermatol. 1977; 113 (9): 1295–6.Dahl KB, Reymann F. Photochemotherapy in erythrodermic seborrhoic dermatitis. Arch Dermatol. 1977; 113 (9): 1295–6.Давидович М. И. Опыт применения УФБ 311 нм в лечении себорейного дерматита. РМЖ. № 9 от 20.05.2015.Davidovich M.I. Experience of using UVB311 nm in the treatment of seborrheic dermatitis. Regular issues of RMJ No. 9 from 20.05.2015 (in Russian).Pirkhammer D, Seeber A, Honigsmann H, Tanew A. Narrow-band ultraviolet B (ATL 01) phototherapy is an effective and safe treatment option for patients with severe seborrheic dermatitis. Br J Dermatol. 2000; 143 (5): 964–8Pirkhammer D, Seeber A, Honigsmann H, Tanew A. Narrow-band ultraviolet B (ATL 01) phototherapy is an effective and safe treatment option for patients with severe seborrheic dermatitis. Br J Dermatol. 2000; 143 (5): 964–8Sigmundsdottir H., Johnston A., Gudjonsson J.E. et al. Narrowband-UVB irradiation decreases the production of pro-inflammatory cytokines by stimulated T cells. Arch. Dermatol. Res. 2005. Vol. 297, No. 1. P. 39–42.Sigmundsdottir H., Johnston A., Gudjonsson J.E. et al. Narrowband-UVB irradiation decreases the production of pro-inflammatory cytokines by stimulated T cells. Arch. Dermatol. Res. 2005. Vol. 297, No. 1. P. 39–42

The authors declare that there are no conflicts of interest present.